Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol. 2022 May;23(5):625-635. doi: 10.1016/S1470-2045(22)00159-0. Epub 2022 Apr 8.
Lancet Oncol. 2022.
PMID: 35405088
Clinical Trial.
Elimination half-life of anti-Müllerian hormone.
Griesinger G, Dafopoulos K, Buendgen N, Cascorbi I, Georgoulias P, Zavos A, Messini CI, Messinis IE.
Griesinger G, et al. Among authors: buendgen n.
J Clin Endocrinol Metab. 2012 Jun;97(6):2160-3. doi: 10.1210/jc.2012-1070. Epub 2012 Mar 22.
J Clin Endocrinol Metab. 2012.
PMID: 22442264
Item in Clipboard
Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.
Buendgen NK, et al.
Arch Gynecol Obstet. 2013 Oct;288(4):901-4. doi: 10.1007/s00404-013-2794-z. Epub 2013 Apr 3.
Arch Gynecol Obstet. 2013.
PMID: 23545834
Clinical Trial.
Item in Clipboard
Cite
Cite